Trial intelligence / Profile preview

Mycophenolate mofetil after PTA for AVF stenosis in dialysis patients

ChiCTR2100042719Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of mycophenolate mofetil in arteriovenous fistula stenosis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: AVF re-stenosis rate. Started Jan 2021; status: recruiting.

02

Drugs

mycophenolate mofetil
03

Conditions

arteriovenous fistula stenosis

Beyond the preview

Go deeper on ChiCTR2100042719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100042719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call